Secondary Logo

Journal Logo

April 2012 - Volume 22 - Issue 4
pp: 229-325

A genome-wide association study identifies four genetic markers for hematological toxicities in cancer patients receiving gemcitabine therapy

Kiyotani, Kazuma; Uno, Satoko; Mushiroda, Taisei; More

Pharmacogenetics and Genomics. 22(4):229-235, April 2012.

Merging pharmacometabolomics with pharmacogenomics using ‘1000 Genomes’ single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomics

Abo, Ryan; Hebbring, Scott; Ji, Yuan; More

Pharmacogenetics and Genomics. 22(4):247-253, April 2012.